Trial Profile
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2014
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- Sponsors Amgen
- 10 Jun 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.